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Material and Methods
S1 In vitro digestion 
Digestion by pepsin (Sigma-Aldrich, Munich, Germany) 
was performed at a ratio of 10 U of pepsin activity per 1 
microgram of protein at pH 1.20.1 Samples were incubated at 
37 °C for 1, 5, 15, 45 and 180 min and aliquots of 100 µL were 
taken and the reaction was stopped by adding 30 µL of 2 M 
sodium bicarbonate, followed by adding 33 µL of reducing 
Laemmli buffer and boiling for 5 min at 95 °C. Controls had no 
pepsin added. After digestion, the samples (50 µL of each) 
were analysed in duplicate on 16% SDS-polyacrylamide gels, 
using Tris-glycine buffer system.2 The voltage was kept at 100 
V until the dye front reached separating gel, and then was 
increased to 200 V and kept constant.2 The total run time was 2 
h. 
S2 Basophil activation 
Basophil activation tests were performed as described 
previously.3 Briefly, heparinized blood samples were taken 
from 4 peanut-allergic patients. The study was approved by the 
Ethical Committee of the University Children’s Hospital, 
Belgrade, Serbia (Approval number: 017/6-990/66). All 
participants gave informed consent to participate in the study.
For activation assays, blood aliquots (100 µL) were incubated 
with allergens at four different concentrations (range 0.05-50 
µg mL-1), anti-IgE antibody as a positive control (10 µg mL-1), 
or PBS as a negative control, for 15 min (37 °C). After 
incubation, cells were washed in PBS and then incubated with 
10 µL of phycoerythrin-labelled CD203c monoclonal antibody 
97A6 (Immunotech, Marseille, France) and FITC-labelled 
CD63 monoclonal antibody (Immunotech, Marseille, France) 
for 15 min at room temperature. Thereafter, samples were 
subjected to erythrocyte lysis with 2.0 mL of FACS lysing 
solution (BD Biosciences, San Jose, CA, USA). Cells were then 
washed, resuspended in PBS, and analyzed by flow cytometry 
on a FACSCalibur flow cytometer (BD Biosciences, San Jose, 
CA, USA). The basophil marker CD203c was used to set a 
basophil gate including only CD203c+ cells. The collected cells 
were further analyzed for granule release using an anti-CD63 
antibody. The extent of basophil activation (BA) was calculated 
as the percentage of CD63+ events among the gated basophils 
(CD63+/CD203c+ cells). 
S3 Human IgE binding
Human sera were taken from patients of both genders, aged 
19-45, selected on the basis of positive skin prick testing to 
peanuts, documented clinical history of allergy to peanut and 
positive in vitro testing: IgE levels were assessed with an 
ImmunoCAP®100 system using ImmunoCAP® code f13 
(Phadia Diagnostics, Uppsala, Sweden). Levels were 
considered positive if above 0.35 kAU L-1. Pooled sera used in 
immunoblot experiments were obtained from 7 patients and had 
an average of 37.00 kAU L-1. Pooled sera used in ELISA 
inhibition experiments were obtained from 14 patients and had 
an average of 30.80 kAU L-1. Prior to use all sera were 
centrifuged for 15 min at 10,000 x g. All the sera used in IgE 
binding experiments were obtained at University Children’s 
Hospital, Belgrade, Serbia (Approval: 017/6-990/66).
S3.1 Immunoblot
To study the immunoreactivity of peanut allergenic 
proteins, 12% SDS-PAGE gels were prepared2 and the 
separated protein cross-links were transferred to nitrocellulose 
membrane (Roti-NC, Carl Roth GmbH, Munich, Germany), 
according to Towbin et al.4 Electrotransfer was performed at 
1.5 mA cm-2 of membrane surface for 45 min.
After electrotransfer, membrane was blocked with 1.00% BSA 
in TTBS for 3 h and incubated with a pool of peanut allergic 
patient sera (diluted 1:5 (v:v) with TTBS). Bound IgE was 
detected using mouse anti-human IgE antibodies (Sigma–
Aldrich, Munich, Germany), labelled with alkaline 
phosphatase, diluted in TTBS supplemented with 0.10% BSA 
in appropriate dilutions (1:2,000). The binding patterns were 
visualized with a substrate solution consisting of 1.5 mg BCIP 
(5-bromo-4-chloro-3-indolyl phosphate) and 3.0 mg NBT 
(nitrobluetetrazolium) in 10.0 mL of 100 mM Tris buffer, 
containing 150 mM NaCl, and 5 mM MgCl2, pH 9.60. 
Developed membrane was scanned with Epson Perfection 
V330 scanner (Epson, Tokyo, Japan) at 600 dpi resolution in 
grayscale mode. 
S3.2 Inhibition ELISA for determination of IgE binding potency 
of cross-linked peanut proteins
Materials for inhibitions were prepared at 10 fold serial 
dilutions and preincubated for 1 h with the aliquots of the 
human sera pool (final dilution: 60 fold). 
Costar ELISA plates (Corning, San Diego, CA, USA) were 
coated overnight with 100 µL of peanut proteins in PBS 
(concentration: 10.0 mg mL-1). After washing with TPBS, 
blocking with 1.00% BSA in TPBS for 1 h and a washing step 
with TPBS, preincubated sera (100 µL) were applied onto 
plates and incubated for 2 h. Subsequently, plates were washed 
and incubated with goat-anti-human IgE-HRP conjugated 
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antibodies (Pharmingen, San Diego, CA, USA) for 1 h. ELISA 
was visualized with 100 µL TMB substrate solution (0.1 mg 
mL-1). The reaction was stopped after 15 min with 50 µL 1 M 
H2SO4 and optical density at 450 nm was measured.
Percentage of inhibition (% of inhibition) was expressed as 
(A450 noninhibited - A450 inhibited) / A450 noninhibited × 100%. 
Results
Susceptibility of obtained material to pepsinolysis
Pepsinolysis of the untreated and laccase-treated peanut 
extracts was performed to investigate effects of the laccase 
treatment on proteins’ stability in the acidic environment and 
resistance to action of proteases. Unlike the untreated peanut 
extract, laccase-treated peanut proteins showed prolonged 
survival of high molecular weight aggregates for over 3 h. 
(Figure S1)
Figure S1: Pepsinolysis of peanut extract and laccase-treated peanut extract: PE, 
LC - peanut extract and laccase-treated peanut extract, respectively, 1’, 5’, 15’, 
45’, 180’ - duration of pepsinolysis (in min). Pe and P0 – pepsin only at 180 and 0 
min of digestion, MM – molecular weight markers (in kDa). Experiment was 
performed in duplicate, a sample gel is shown. All samples are analysed in the 
same gel. Vertical black line indicates discontinuation in the gel.
Human IgE binding to laccase-modified peanut proteins
Effects of modifications by laccase on binding of peanut 
proteins to human IgE were investigated by basophil activation 
assays, immunoblot and inhibition ELISA.
Basophils were stimulated with laccase-treated material in 
the similar manner as with unmodified peanut extract (Figure 
S2). 
Figure S2: Four peanut-allergic patients’ basophil activation with peanut extract 
(PE) and laccase-treated peanut extract (LC). 
In order to quantify the effects of cross-linking on 
allergenicity of peanut proteins, inhibition assays by ELISA 
were performed with pooled peanut allergic patient sera and 
IC50 was determined (Figure S3B). The obtained IC50 values for 
untreated PE were within the same order of magnitude as cross-
linked proteins which implies that no significant modification 
of IgE binding epitopes of peanut proteins occurred when 
peanut proteins were modified by the cross-linking enzyme. An 
immunoblot using pool of peanut-allergic patients’ sera and 
detection of bound IgE (Figure S3A) appeared to show a certain 
degree of reduction of IgE binding, but these results should be 
interpreted with caution. As the protein bands were smeared 
due to cross-linking, it was not possible to directly compare 
band intensities between samples. A 66 kDa band (presumably 
Ara h 1) was visible in both samples. A reactive band could be 
observed at the top of the gel in the laccase-treated peanut 
extract, indicating that IgE binding was preserved in the 
obtained cross-links of high molecular weight. 
In line with this, linear epitopes in peanut allergic subjects 
tested seemed to be more important than conformational. 
Figure S3: Human IgE binding to peanut extract (PE) and laccase-treated peanut 
extract (LC). A – immunoblot. MM – molecular weight markers (in kDa); B – ELISA 
inhibition.
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